News

MONDAY, July 7, 2025 (HealthDay News) — Adults as young as 50 may now qualify for an RSV vaccine if they have certain health ...
GSK has applied to the US Food and Drug Administration (FDA) to extend use of its respiratory syncytial virus (RSV) vaccine Arexvy to adults under the age of 50 who are at increased risk of the ...
The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...
The update covers the safety and appropriate timing of vaccinations, screening for osteoporosis, cervical cancer, skin cancer ...
The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV.
Cases of COVID-19 are on the rise or likely rising across half of the U.S. including much of the south as well as the West Coast, according to a weekly update from the Centers for Disease Control and ...
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...
Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.
RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...
Failure to recognize and resolve problems in an honest and evidence-based manner is the root cause of increasing vaccine ...
Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and answers are republished by permission.